跳至主要内容
临床试验/NCT04957888
NCT04957888Unknown不适用

Investigation on the Microbial Biomarkers of AGI in the Early Stage

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 584 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
584
试验地点
1
主要终点
The AUC value of the combined markers

研究概览

简要总结

AGI is very common in ICU and sometimes will trigger the development of gut derived sepsis. Thus, to find out the biomarker in early stage is very important to improve the overall prognosis of critically ill patients. In this project we try to find out the microbial biomarker of AGI through multi-omic technology.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All those critically ill patients with anticipated ICU stay for more than 2 days

排除标准

  • Patients will be excluded if they have any of the following situations: patients who have not signed the informed consent; Unable to tolerate intra-abdominal pressure monitoring; pregnant woman; Patients after bladder surgery; Systemic diseases and recent use of related drugs; He had a history of infectious diseases, such as tuberculosis or PPD positive. History of hypertension and poor blood pressure control (SBP / DBP > = 140mmHg); Patients with severe mental illness; Long term use of traditional Chinese medicine, probiotics, gastric mucosal protective agents, proton pump inhibitors, chemotherapy or immunosuppressive drugs, etc. were not included if the drug was not stopped within one month before admission.

结局指标

主要结局

The AUC value of the combined markers

时间窗: 1 year

The combined diagnostic accuracy of AGI through omic parameters

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验